Anti-inflammatory and Cytoprotective Mechanisms Beyond promoting angiogenesis and growth factor responsiveness, BPC-157 exerts direct anti-inflammatory and cytoprotective effects at the cellular level
remission: When the provider documents Crohns disease in remission, assign the appropriate K50.x0 code (without complications, e.g., K50.00, K50.10, K50.80, K50.90)
According to the National Institutes of Health (NIH), no Tolerable Upper Intake Level (UL) has been established for B12, indicating that the risk of harm from high doses is low [*]
Some researchers stay at a given dose longer than 4 weeks if they are still seeing results
Maybe not so much
This is a plausible biological hypothesis, and it is the reasoning most often cited in research-community discussions of combined protocols